LCZ696, an angiotensin receptor-neprilysin inhibitor, improves cardiac function with the attenuation of fibrosis in heart failure with reduced ejection fraction in streptozotocin-induced diabetic mice

Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients

(2015) Akshay S. Desai et al.   EUROPEAN HEART JOURNAL

MicroRNA signatures differentiate preserved from reduced ejection fraction heart failure

(2015) Chris J. Watson et al.   EUROPEAN JOURNAL OF HEART FAILURE

Pre-treatment with LCZ696, an orally active angiotensin receptor neprilysin inhibitor, prevents ischemic brain damage

(2015) Hui-Yu Bai et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Atrial natriuretic peptide in cardiovascular biology and disease (NPPA)

(2015) Wei Song et al.   GENE

The potential role of valsartan + AHU377 (LCZ696) in the treatment of heart failure

(2013) Adriaan A Voors et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Effects of the novel angiotensin II receptor type I antagonist, fimasartan on myocardial ischemia/reperfusion injury

(2013) Jin Han et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Use of Hydralazine‐Isosorbide Dinitrate Combination in African American and Other Race/Ethnic Group Patients With Heart Failure and Reduced Left Ventricular Ejection Fraction

(2013) Harsh B. Golwala et al.   Journal of the American Heart Association

Chronic Inhibition of cGMP Phosphodiesterase 5A Improves Diabetic Cardiomyopathy

(2012) Elisa Giannetta et al.   CIRCULATION

The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial

(2012) Scott D Solomon et al.   LANCET

Pharmacokinetics and Pharmacodynamics of LCZ696, a Novel Dual-Acting Angiotensin Receptor-Neprilysin Inhibitor (ARNi)

(2009) Jessie Gu et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Measurement of cardiac function using pressure–volume conductance catheter technique in mice and rats

(2008) Pál Pacher et al.   Nature Protocols

Effect of bradykinin metabolism inhibitors on evoked hypotension in rats: rank efficacy of enzymes associated with bradykinin-mediated angioedema

(2007) R M Fryer et al.   BRITISH JOURNAL OF PHARMACOLOGY